CytomX Therapeutics, Inc. Taxes Payable, Current
CytomX Therapeutics, Inc. (CTMX) had Taxes Payable, Current of $13.37 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2020-02-27
- 2019-03-31: Taxes Payable, Current $13.37M.
- 2018-12-31: Taxes Payable, Current $13.34M.
- 2018-09-30: Taxes Payable, Current $4.99M.
- 2018-06-30: Taxes Payable, Current $2.69M.
| Period end | Taxes Payable, Current |
|---|---|
| 2019-03-31 | $13.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $13.34M 10-K · filed 2020-02-27 |
| 2018-09-30 | $4.99M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.69M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.03M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |